期刊文献+

137株肠球菌的临床分布及耐药性分析 被引量:3

Analysis on Drug-tolerance and Clinical Distribution of 137 Strains of Enterococcus
下载PDF
导出
摘要 目的 了解肠球菌引起院内感染的临床分布及肠球菌对常用抗菌药的耐药状况,指导临床合理用药。方法 按《全国临床检验操作规程》及Sensititre Aris全自动细菌鉴定仪鉴定各临床标本分离的肠球菌,分别进行纸片扩散法药敏试验和β-内酰胺酶测试,并以WHONET软件对试验数据进行分析处理。结果137株肠球菌属中粪肠球菌占91.2%,屎肠球菌占7.3%,其他肠球菌占1.5%,产β-内酰胺酶的肠球菌占6.%,对万古霉素耐药率为2.9%,高浓度庆大霉素耐药率为76.6%,替考拉宁耐药率最低。肠球菌在各类感染性标本中的检出率以尿液最多,占42.3%。结论 肠球菌是造成医院感染的主要病原菌之一,以粪肠球菌多见。临床上以泌尿系统、呼吸系统感染为主;肠球菌存在严重耐药性,屎肠球菌耐药高于粪肠球菌;对不同肠球菌感染应采取不同治疗方案。 Objective To learn the clinical distribution of hospital infection caused by enterococcus and drug-tolerance of enterococcus to commo Method National clinical operation rules and sensititre Aris toi- dentify enterococcus separated from clinical specimen paper distribution drug sensitive test andβ- lactamase test,and using WHONET software to analyze data.Results The feces enterococcus wsa 91.2% in 137 strains of enterococcus,and the enterococcus was 7.3%;enterococcus producing β-lactamase was 6.6%;the rate of drug-tolerance to vancomycin was 2.9%;the rate of drug- tolerance to high chroma gentamicin was 76.6%.The rate of enterococcus in urine specimen was the highest among all kinds of infec- tion Specimen,(42.3%).Conclusions Enterococcus was one of main bacteria that caused hospital infec- tion,and feces enterococcus was the primary.The infection of urinary system and respiratory System was pri- mary and the drug-tolerance of enterococcus was severe We should varied therapy project to cure differ- ent enterococcus infection.
出处 《疾病监测》 CAS 2004年第4期127-129,共3页 Disease Surveillance
关键词 肠球菌 耐药性 院内感染 抗菌药 Enterococcus Drug-tolerance Hospital infection
  • 相关文献

参考文献7

  • 1张秀珍.当代细菌检验与临床(M).北京:人民卫生出版社,1999:373-420. 被引量:1
  • 2应春妹.耐糖肽类抗生素的革兰阳性细菌(J)[J].国外医学微生物分册,2000,23(7):286-288. 被引量:1
  • 3余美凤,俞月琴,孙玉兰,凌代文.医院感染菌及耐药性监测的3年报告[J].中华医院感染学杂志,1997,7(1):48-50. 被引量:48
  • 4Rice LB, Shlaes DM. Vancomycin resistance in the enterococcus. Pediatr Clin North Am, 1995, 42:601-617. 被引量:1
  • 5Nicoletti G, Stefani S. Enterococci: Susceptibility patterns and therapeutic options. Eur J Clin Microbiol Infect Dis, 1995, 14(Suppl) 1 :S33 - 37. 被引量:1
  • 6Brandt CM, Rouse MS, Laue NW, et al. Effective treatment of multidrugresistant enterococcal experimental endocarditis with combinations of cell wallactive agents. J Infect Dis, 1996, 173:909-913. 被引量:1
  • 7王清涛,徐英春,王辉,陈民钧,张秀珍,许淑珍,吴坚.肠球菌耐药现状调查及抗感染用药探讨[J].中华医学检验杂志,1999,22(3):154-156. 被引量:132

二级参考文献2

  • 1张群智,中华医学检验杂志,1998年,21卷,73页 被引量:1
  • 2马俊春,中华医学检验杂志,1995年,18卷,164页 被引量:1

共引文献178

同被引文献14

  • 1罗燕萍,白立彦,李俊玲,许淑秀.211株肠球菌属细菌对18种抗生素的耐药性特征[J].中华医院感染学杂志,2004,14(1):80-82. 被引量:68
  • 2周青,杨祚升,唐曼娟,阮卫.254株肠球菌的分布及耐药性分析[J].中国现代医学杂志,2006,16(11):1682-1684. 被引量:7
  • 3QUEDNAU M,AHRNE S,PETERSSON AL et al.Identification of clinically important species of Enterococci withim 1 day with randomly amplified polymorphic DNA (RAPD)[J].Current Mic,1998,36:332-336. 被引量:1
  • 4ANBING K E,FRANCOIS J,FRANOIS M,et al.Development of a PCR assay for rapid detection of enterococci[J].J Clin Microbiology,1999,37:3497-3503. 被引量:1
  • 5Quednau M.Ahrne S,Petersson AL,et al.Identification of clinically important species of Enterococci withim 1 day with randomly amplified polymorphic DNA(RAPD)[J].Current Mic.1998,36:332-336. 被引量:1
  • 6叶应妩,王毓三.全国l临床检验操作规程[M].南京:东南大学出版社,1997:500-561. 被引量:1
  • 7Quednau M, Ahrne S, Petersson AL, at al. Identification of dinically important species of enterococci withim 1 day with randomly amplified polymorphic DNA (RAPD) [J]. Current Mic, 1998, 36: 332-336. 被引量:1
  • 8Anbing KE, Francois J, Franois M, et al. Development of a PCR assay for rapid detection of enterococei[J]. J Clin Microbiology, 1999, 37: 3497-3503. 被引量:1
  • 9李光辉,张婴元.肠球菌感染研究进展[J].国外医学(内科学分册),1999,26(11):471-474. 被引量:42
  • 10乐理.肠球菌医院内感染特点及其耐药性[J].现代预防医学,2001,28(4):481-482. 被引量:4

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部